Since the aggressive Activated B Cell (ABC) subtype of DLBCL also demonstrates constitutive activation of BCR signaling [45], the combination was also tested on ABC-DLBCL cell lines. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.